BRCA2 and posterior cortical atrophy: In the 6-mo landmark analysis, the estimated absolute PCa risk by age 85 yr was 26% (95% CI 15–43%) for BRCA1 and 55% (95% CI 36–75%) for BRCA2 carriers.